(Q39994999)

16 September 2017

In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy (English)

1 reference

16 September 2017

Clare L Conway

1

1 reference

16 September 2017

Ian Walker

2

1 reference

16 September 2017

Andrea Bell

3

1 reference

16 September 2017

David J H Roberts

4

1 reference

16 September 2017

Stanley B Brown

5

1 reference

16 September 2017

David I Vernon

6

1 reference

16 September 2017

18 December 2007

1 reference

Photochemical and Photobiological Sciences

16 September 2017

1 reference

16 September 2017

7

1 reference

16 September 2017

3

1 reference

16 September 2017

290-298

1 reference

The present and future role of photodynamic therapy in cancer treatment

16 September 2017

1 reference

Photodynamic therapy for cancer

21 January 2018

1 reference

Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications

21 January 2018

1 reference

Antibacterial photodynamic therapy in dermatology

21 January 2018

1 reference

Photodynamic therapy targeted to tumor-induced angiogenic vessels

21 January 2018

1 reference

Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles

21 January 2018

1 reference

An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells

21 January 2018

1 reference

Photosensitizer-antibody conjugates for detection and therapy of cancer

21 January 2018

1 reference

The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy

21 January 2018

1 reference

Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer.

21 January 2018

1 reference

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels

21 January 2018

1 reference

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

21 January 2018

1 reference

The RGD story: a personal account

21 January 2018

1 reference

RGD and other recognition sequences for integrins

21 January 2018

1 reference

Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.

21 January 2018

1 reference

Solid-phase synthesis of c(RGDfK) derivatives: on-resin cyclisation and lysine functionalisation

21 January 2018

1 reference

Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process

21 January 2018

1 reference

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies

21 January 2018

1 reference

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.

21 January 2018

1 reference

Anti-cancer activity of targeted pro-apoptotic peptides

21 January 2018

1 reference

Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity

21 January 2018

1 reference

The solid-phase conjugation of purpurin-18 with a synthetic targeting peptide.

21 January 2018

1 reference

Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting

21 January 2018

1 reference

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1039/B715141A

1 reference

16 September 2017

1 reference